Found: 15
Select item for more details and to access through your institution.
PINK1 function in health and disease.
- Published in:
- EMBO Molecular Medicine, 2009, v. 1, n. 3, p. 152, doi. 10.1002/emmm.200900024
- By:
- Publication type:
- Article
What Have PINK1 and HtrA2 Genes Told Us about the Role of Mitochondria in Parkinson's Disease?
- Published in:
- Annals of the New York Academy of Sciences, 2008, v. 1147, p. 30, doi. 10.1196/annals.1427.032
- By:
- Publication type:
- Article
Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0062400
- By:
- Publication type:
- Article
PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons.
- Published in:
- PLoS ONE, 2008, v. 3, n. 6, p. 1, doi. 10.1371/journal.pone.0002455
- By:
- Publication type:
- Article
Unraveling LRRK2 Pathogenesis: Common Pathways for Complex Genes?
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 5, p. 1577, doi. 10.1523/JNEUROSCI.5531-09.2010
- By:
- Publication type:
- Article
Enhancing nucleotide metabolism protects against mitochondrial dysfunction and neurodegeneration in a PINK1 model of Parkinson's disease.
- Published in:
- Nature Cell Biology, 2014, v. 16, n. 2, p. 157, doi. 10.1038/ncb2901
- By:
- Publication type:
- Article
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1.
- Published in:
- Nature Cell Biology, 2007, v. 9, n. 11, p. 1243, doi. 10.1038/ncb1644
- By:
- Publication type:
- Article
Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis.
- Published in:
- Nature Cell Biology, 2003, v. 5, n. 5, p. 467, doi. 10.1038/ncb984
- By:
- Publication type:
- Article
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Glucocerebrosidase mutations in clinical and pathologically proven Parkinsons disease.
- Published in:
- Brain: A Journal of Neurology, 2009, v. 132, n. 7, p. 1783, doi. 10.1093/brain/awp044
- By:
- Publication type:
- Article
A heterozygous effect for PINK1 mutations in Parkinson's disease?
- Published in:
- Annals of Neurology, 2006, v. 60, n. 4, p. 414
- By:
- Publication type:
- Article
A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation.
- Published in:
- Human Mutation, 2009, v. 30, n. 1, p. 61, doi. 10.1002/humu.20814
- By:
- Publication type:
- Article
PINK1 cleavage at position A103 by the mitochondrial protease PARL.
- Published in:
- Human Molecular Genetics, 2011, v. 20, n. 5, p. 867, doi. 10.1093/hmg/ddq526
- By:
- Publication type:
- Article
Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress.
- Published in:
- Journal of Neurochemistry, 2006, v. 98, n. 1, p. 156, doi. 10.1111/j.1471-4159.2006.03845.x
- By:
- Publication type:
- Article
The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.
- Published in:
- Movement Disorders, 2013, v. 28, n. 2, p. 232, doi. 10.1002/mds.25248
- By:
- Publication type:
- Article